Outsized pay packages have been a hallmark of Robert Coury’s tenure while leading Cecil-based generic drug company Mylan, and last year was no exception.
In 2020 — the year Mylan merged with Upjohn to form Viatris Inc. — Mr. Coury, executive chairman of the combined company, received a payout of $29.1 million, a recent proxy statement filed with the U.S. Securities and Exchange Commission showed.
The total pay package included a base salary of $1.8 million, stock awards, other compensation, plus a lump-sum cash bonus of $10 million.
Mr. Coury, 60, who had served as non-executive chairman at Mylan since 2016, was named executive chairman in April 2020, the second time he held the title. The merger with Upjohn was completed in mid-November 2020 and Mr. Coury remained executive chairman.
When Mr. Coury stepped down as executive chairman at Mylan in 2016, his exit package amounted to some $97 million.
The $10 million cash bonus payout in 2020, which was previously disclosed, “rewarded Mr. Coury for, among other things: the fact that Mr. Coury assumed an executive role with Mylan in April 2020 but did not receive an annual equity grant at that time ... his strategic leadership of Mylan, the unexpected and significantly increased efforts expended by Mr. Coury on company matters since April 2020, including during the COVID-19 pandemic, his significant leadership in the analysis and negotiations relating to the [merger] ... and his expected leadership, direction and efforts for the combined company,” the filing stated.
Read More
Mr. Coury’s compensation for 2020 was roughly five times more than the pay package awarded to former Upjohn executive and current Viatris CEO Michael Goettler, who received a total of $5.5 million in salary, bonus, stock awards and other compensation in 2020, according to the proxy statement.
Following Mr. Coury, the second- and third-highest paid executives in 2020 were two former Mylan executives: Viatris president Rajiv Malik at $14.1 million and Viatris president for developed markets Anthony Mauro, who received $6.7 million, the filing showed.
When asked for comment Wednesday, a Viatris spokeswoman referred questions to the proxy statement.
In the proxy statement, Viatris described 2020 as an “outlier compensation year.”
“It is the year in which our complex, $25 billion transaction was completed and, as a result, 2020 compensation reflects three different compensation programs and certain one-time transaction-related expenses and does not represent the new Viatris compensation program,” the filing said.
So far this year, Viatris’ stock has fallen about 20% — from the $18 range to close Wednesday at $14.54 per share.
On Monday, the company reported profits of $311.5 million, or 26 cents per share, on revenue of $4.54 billion for the third quarter this year. That compared with profits of $185.7 million, or 36 cents, on revenue of $2.97 billion in the same quarter last year.
According to the proxy statement, Viatris, whose corporate offices are in Cecil, will hold its annual shareholders meeting at 11 a.m. Dec. 10 in Naples, Fla.
Patricia Sabatini: PSabatini@post-gazette.com; 412-263-3066.





Comments
Welcome to Post-Gazette subscriber-only commenting community. Please review our community guidelines.